Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use FLUCELVAX® safely and effectively. See full prescribing information for FLUCELVAX. FLUCELVAX (Influenza Vaccine) injectable suspension, for intramuscular use2026-2027 FormulaInitial U.S. Approval: 2012
Medication labelWhy this: Advisory · dailymed-other
FLUCELVAX is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. FLUCELVAX is approved for use in persons 6 months of age and older. [see Clinical Studies (14)]
- generic_name
- influenza a virus a/tasmania/318/2025 cvr-351 (h1n1) antigen (mdck cell derived, propiolactone inactivated), influenza a virus a/tasmania/787/2025 cvr-388 (h3n2) antigen (mdck cell derived, propiolactone inactivated), influenza b virus b/arizona/21/2025 antigen (mdck cell derived, propiolactone inactivated)
- product_names
- INFLUENZA A VIRUS A/Tasmania/318/2025 CVR-351 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Tasmania/787/2025 CVR-388 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Arizona/21/2025 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED)
- ndc
- 70461-656, 70461-656-04, 70461-656-03
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en